Research progress of immunotherapy in locally advanced cervical cancer / 中国肿瘤临床
Chinese Journal of Clinical Oncology
; (24): 1280-1283, 2023.
Article
en Zh
| WPRIM
| ID: wpr-1026744
Biblioteca responsable:
WPRO
ABSTRACT
Cervical cancer is the most common reproductive system malignancy in women.Its primary cause is persistent infection with high-risk human papillomavirus.Traditional treatment methods include surgery,radiotherapy,and chemotherapy,but the prognosis for ad-vanced cervical cancer remains dismal.In recent years,therapeutic vaccines,immune checkpoint inhibitors,adoptive T cell therapy,and oth-er immunotherapies have been widely used in cervical cancer,notably improving patient survival.This article reviews clinical trials and re-cent advances in immunotherapy for in locally advanced cervical cancer(LACC).
Texto completo:
1
Base de datos:
WPRIM
Idioma:
Zh
Revista:
Chinese Journal of Clinical Oncology
Año:
2023
Tipo del documento:
Article